Login to Your Account

Indevus' Sanctura Gets FDA Nod For Overactive Bladder

By Karen Pihl-Carey

Tuesday, June 1, 2004
Breathing a sigh of satisfaction after years of hard work, officials at Indevus Pharmaceuticals Inc. reached a long-awaited milestone on Friday with the FDA approval of Sanctura. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription